We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
AstraZeneca PLC | NYSE:AZN | NYSE | Depository Receipt |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 54.17 | 0 | 01:00:00 |
This article is being republished as part of our daily reproduction of WSJ.com articles that also appeared in the U.S. print edition of The Wall Street Journal (September 9, 2020).
Public-health experts are increasingly calling for a shift in thinking about Covid-19 testing, saying it is better to get fast, frequent results that are reasonably accurate than more precise results after dayslong delays.
Nine drugmakers said their CEOs signed a pledge to not file for regulatory approval or authorization of their experimental Covid-19 vaccines until the shots are shown to work safely.
AstraZeneca said it paused clinical trials of an experimental vaccine after a participant in a U.K. study had an unexplained illness.
Senate Republicans proposed a new, smaller package of coronavirus aid aimed at unifying the party and bolstering it politically, as talks with Democrats remained at a standstill.
The police chief of Rochester, N.Y., and two deputy chiefs resigned after days of protests and mounting criticism over the death of Daniel Prude.
Powerful windstorms in California are creating more dangerous conditions as firefighters work to contain wildfires that have already burned a record 2.3 million acres.
The Indian and Chinese militaries accused each other of firing warning shots in what would be the first use of guns along their disputed border in decades.
(END) Dow Jones Newswires
September 09, 2020 02:47 ET (06:47 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year AstraZeneca Chart |
1 Month AstraZeneca Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions